Status:
UNKNOWN
The Effects of Remifentanil on Attenuating the Hemodynamic Responses After Electroconvulsive Therapy
Lead Sponsor:
Inonu University
Conditions:
Haemodynamic Rebound
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The investigators will be evaluated the effects of a single loading dose of remifentanil (1µg/kg), administered as an adjunct to sevoflurane, on duration of hemodynamic profile, seizure activity, and ...
Detailed Description
Major depressive patients will enrolled this trial. Mean arterial pressure (MAP) and heart rate (HR) and peripheral oxygen saturation values will be recorded prior to anesthetic induction (T1); follow...
Eligibility Criteria
Inclusion
- Major depressive patients
Exclusion
- younger than 18 years, pregnant, had a history of myocardial infarction in the previous six months, atrial fibrillation or flutter, heart block, unregulated hypertension, cerebrovascular diseases, known drug allergy.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT02271555
Start Date
October 1 2014
End Date
December 1 2014
Last Update
October 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turgut Ozal Medical Center
Malatya, Turkey (Türkiye), 44315